Abstract
A 19-year-old man complaining of severe diarrhea and hematochezia was admitted to our hospital. Endoscopic findings and laboratory data revealed that he had ulcerative colitis (UC). Despite combination therapy with high-dose corticosteroids and intensive granulocytapheresis, his condition did not improve. Therefore, we initiated tacrolimus therapy. Intravenous administration of tacrolimus with a trough level of 10 to 15 ng/ml relieved his abdominal symptoms within 1 week. The patient experienced no UC relapse 1 year after treatment with oral tacrolimus. Tacrolimus is a promising therapy for patients with UC refractory to the combination of high-dose corticosteroids and leukocytapheresis. © 2007 The Japanese Society of Internal Medicine.
Author supplied keywords
Cite
CITATION STYLE
Nakase, H., Mikami, S., Matsuura, M., Ueno, S., Uza, N., Inoue, S., … Chiba, T. (2007). Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy. Internal Medicine, 46(11), 717–720. https://doi.org/10.2169/internalmedicine.46.6219
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.